{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:49:43Z","timestamp":1775166583827,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.modpat.2023.100126","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T02:12:51Z","timestamp":1675735971000},"page":"100126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non\u2013Small Cell Lung Carcinomas"],"prefix":"10.1016","volume":"36","author":[{"given":"Ying-Chun","family":"Lo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna H.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Odintsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette M.","family":"Sholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3769-0247","authenticated-orcid":false,"given":"Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2023.100126_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"Lindeman","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2023.100126_bib2","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.5858\/arpa.2016-0542-CP","article-title":"A\u00a0window into clinical next-generation sequencing\u2013based oncology testing practices","volume":"141","author":"Nagarajan","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2023.100126_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00169","article-title":"Use of next-generation sequencing tests to guide cancer treatment: results from a nationally representative survey of oncologists in the United States","volume":"2","author":"Freedman","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2023.100126_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103194","article-title":"Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives","volume":"157","author":"Imyanitov","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.modpat.2023.100126_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","article-title":"Cancer of unknown primary site","volume":"379","author":"Pavlidis","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.modpat.2023.100126_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAI.0b013e318205b059","article-title":"Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung","volume":"19","author":"Ye","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.modpat.2023.100126_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1309\/21TW-2NDG-JRK4-PFJX","article-title":"Value of p63 and cytokeratin 5\/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas","volume":"116","author":"Kaufmann","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2023.100126_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAP.0b013e3182a28a24","article-title":"Is immunohistochemistry always required to diagnose lung cancer?","volume":"20","author":"Rossi","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.modpat.2023.100126_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.modpat.2023.100126_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of oncopanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2023.100126_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12377","article-title":"UV signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.modpat.2023.100126_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2023.100126_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2023.100126_bib14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/bjc.2014.36","article-title":"RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis","volume":"110","author":"Tsuta","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.modpat.2023.100126_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/thy.2017.0318","article-title":"Gene fusions in thyroid cancer","volume":"28","author":"Yakushina","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.modpat.2023.100126_bib16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","article-title":"Metastatic patterns of cancers: results from a large autopsy study","volume":"132","author":"Disibio","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2023.100126_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jtho.2018.12.005","article-title":"Best practices recommendations for diagnostic immunohistochemistry in lung cancer","volume":"14","author":"Yatabe","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.modpat.2023.100126_bib18","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/s41379-020-0594-0","article-title":"Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma","volume":"33","author":"Yang","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2023.100126_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3833","article-title":"Prevalence of UV mutational signatures among cutaneous primary tumors","volume":"5","author":"Mata","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.modpat.2023.100126_bib20","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer","volume":"10","author":"Silk","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.modpat.2023.100126_bib21","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMra2034861","article-title":"Recent advances in the treatment of melanoma","volume":"384","author":"Curti","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.modpat.2023.100126_bib22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtho.2019.05.008","article-title":"Using genomics to differentiate multiple primaries from metastatic lung cancer","volume":"14","author":"Murphy","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.modpat.2023.100126_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.modpat.2023.100126_bib24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jamaoncol.2020.4643","article-title":"Site-specific and targeted therapy based on molecular profiling by next-generation sequencing for cancer of unknown primary site: a nonrandomized phase 2 clinical trial","volume":"6","author":"Hayashi","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.modpat.2023.100126_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jmoldx.2022.01.011","article-title":"Defining novel DNA virus-tumor associations and genomic correlates using prospective clinical tumor\/normal matched sequencing data","volume":"24","author":"Vanderbilt","year":"2022","journal-title":"J\u00a0Mol Diagn"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:24:14Z","timestamp":1760232254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0893395223000315"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100126","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non\u2013Small Cell Lung Carcinomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100126"}}